Focal adhesion kinase inhibition synergizes with nab-paclitaxel to target pancreatic ductal adenocarcinoma

被引：0
|
作者：
T. Y. S. Le Large
M. F. Bijlsma
B. El Hassouni
G. Mantini
T. Lagerweij
A. A. Henneman
N. Funel
B. Kok
T. V. Pham
R. de Haas
L. Morelli
J. C. Knol
S. R. Piersma
G. Kazemier
H. W. M. van Laarhoven
E. Giovannetti
C. R. Jimenez
机构：
[1] VU University Amsterdam,Department of Surgery, Cancer Center Amsterdam, Amsterdam University Medical Centers
[2] VU University,Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers
[3] University of Amsterdam,Laboratory for Experimental Oncology and Radiobiology, Cancer Center Amsterdam, Amsterdam University Medical Center
[4] VU University,OncoProteomics Laboratory, Department of Medical Oncology, Cancer, Cancer Center Amsterdam, Amsterdam University Medical Centers
[5] Oncode Institute,Cancer Pharmacology Lab, AIRC
[6] Fondazione Pisana per la Scienza,Start
[7] VU University Amsterdam,Up
[8] Azienda Ospedaliero-Universitaria Pisana,Department of Neurosurgery, Cancer Center Amsterdam, Amsterdam University Medical Centers
[9] University of Amsterdam,Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Center
来源：
Journal of Experimental & Clinical Cancer Research | / 40卷
关键词：
Pancreatic cancer; Therapy; FAK; EPHA2; MET; Phosphoproteomics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Focal adhesion kinase inhibition synergizes with nab-paclitaxel to target pancreatic ductal adenocarcinoma
    Le Large, T. Y. S.
    Bijlsma, M. F.
    El Hassouni, B.
    Mantini, G.
    Lagerweij, T.
    Henneman, A. A.
    Funel, N.
    Kok, B.
    Pham, T., V
    de Haas, R.
    Morelli, L.
    Knol, J. C.
    Piersma, S. R.
    Kazemier, G.
    van Laarhoven, H. W. M.
    Giovannetti, E.
    Jimenez, C. R.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
  • [2] Modified gemcitabine plus nab-paclitaxel regimen in advanced pancreatic ductal adenocarcinoma
    Rogers, Jane E.
    Mizrahi, Jonathan D.
    Xiao, Lianchun
    Mohindroo, Chirayu
    Shroff, Rachna T.
    Wolff, Robert
    Varadhachary, Gauri R.
    Javle, Milind M.
    Overman, Michael
    Fogelman, David R.
    Raghav, Kanwal P. S.
    Pant, Shubham
    McAllister, Florencia
    CANCER MEDICINE, 2020, 9 (15): : 5406 - 5415
  • [3] Nab-Paclitaxel Monotherapy in Refractory Pancreatic Adenocarcinoma
    Peddi, P. F.
    Wang, J.
    Wang-Gillam, A.
    PANCREAS, 2012, 41 (08) : 1395 - 1395
  • [4] Nab-paclitaxel monotherapy in refractory pancreatic adenocarcinoma
    Peddi, Parvin F.
    Cho, May
    Wang, Jian
    Gao, Feng
    Wang-Gillam, Andrea
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2013, 4 (04) : 370 - 373
  • [5] First line gemcitabine and nab-paclitaxel chemotherapy for localized pancreatic ductal adenocarcinoma.
    Gulhati, Pat
    Prakash, Laura
    Katz, Matthew H. G.
    Wang, Xuemei
    Javle, Milind M.
    Shroff, Rachna T.
    Fogelman, David R.
    Lee, Jeffrey Edwin
    Tzeng, Ching-Wei David
    Lee, Jeffrey H.
    Weston, Brian
    Tamm, Eric P.
    Bhosale, Priya
    Koay, Eugene Jon
    Maitra, Anirban
    Wang, Huamin
    Wolff, Robert A.
    Varadhachary, Gauri R.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [6] Efficacy and tolerance of gemcitabine and nab-paclitaxel in elderly patients with advanced pancreatic ductal adenocarcinoma
    Pignon, Flore
    Turpin, Anthony
    Hentic, Olivia
    Coriat, Romain
    Salmon, Emma
    Baumgaertner, Isabelle
    Bertrand, Nicolas
    Levy, Philippe
    Rebours, Vinciane
    Hammel, Pascal
    de Mestier, Louis
    PANCREATOLOGY, 2021, 21 (06) : 1064 - 1070
  • [7] First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma
    Gulhati, Pat
    Prakash, Laura
    Katz, Matthew H. G.
    Wang, Xuemei
    Javle, Milind
    Shroff, Rachna
    Fogelman, David
    Lee, Jeffrey E.
    Tzeng, Ching-Wei D.
    Lee, Jeffrey H.
    Weston, Brian
    Tamm, Eric
    Bhosale, Priya
    Koay, Eugene J.
    Maitra, Anirban
    Wang, Huamin
    Wolff, Robert A.
    Varadhachary, Gauri R.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (02) : 619 - 627
  • [8] First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma
    Pat Gulhati
    Laura Prakash
    Matthew H. G. Katz
    Xuemei Wang
    Milind Javle
    Rachna Shroff
    David Fogelman
    Jeffrey E. Lee
    Ching-Wei D. Tzeng
    Jeffrey H. Lee
    Brian Weston
    Eric Tamm
    Priya Bhosale
    Eugene J. Koay
    Anirban Maitra
    Huamin Wang
    Robert A. Wolff
    Gauri R. Varadhachary
    Annals of Surgical Oncology, 2019, 26 : 619 - 627
  • [9] A study of relacorilant in combination with nab-paclitaxel in patients with metastatic pancreatic ductal adenocarcinoma.
    Borazanci, Erkut Hasan
    Bahary, Nathan
    Oberstein, Paul Eliezer
    Chung, Vincent
    Skeel, Roland T.
    Chiorean, E. Gabriela
    Greenstein, Andrew E.
    Pashova, Hristina I.
    Tudor, Iulia Cristina
    Mann, Grace
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [10] Combination chemotherapy with gemcitabine and nab-paclitaxel for a metastatic pancreatic ductal adenocarcinoma patient undergoing hemodialysis
    Takashi Kaneko
    Kazuya Sugimori
    Yuichiro Tozuka
    Taito Fukushima
    Kazuya Okada
    Hiroyuki Oka
    Hiroshi Okazaki
    Shin Maeda
    Clinical Journal of Gastroenterology, 2019, 12 : 484 - 489
12345